BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND PSIP1, PSIP2, 11168, ENSG00000164985
4 results:

  • 1. Breast cancer incidence in BRCA mutation carriers with ovarian cancer: A longitudal observational study.
    Safra T; Waissengrin B; Gerber D; Bernstein-Molho R; Klorin G; Salman L; Josephy D; Chen-Shtoyerman R; Bruchim I; Frey MK; Pothuri B; Muggia F
    Gynecol Oncol; 2021 Sep; 162(3):715-719. PubMed ID: 34172288
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Fallopian tube abnormalities in uterine serous carcinoma.
    Steenbeek MP; Bulten J; Snijders MPLM; Lombaers M; Hendriks J; van den Brand M; Kraayenbrink AA; Massuger LFAG; Sweegers S; de Hullu JA; Pijnenborg JMA; Küsters-Vandevelde HVN; Reijnen C
    Gynecol Oncol; 2020 Aug; 158(2):339-346. PubMed ID: 32409160
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Germline polymorphisms in an enhancer of psip1 are associated with progression-free survival in epithelial ovarian cancer.
    French JD; Johnatty SE; Lu Y; Beesley J; Gao B; Kalimutho M; Henderson MJ; Russell AJ; Kar S; Chen X; Hillman KM; Kaufmann S; Sivakumaran H; O'Reilly M; Wang C; Korbie DJ; ; ; Lambrechts D; Despierre E; Van Nieuwenhuysen E; Lambrechts S; Vergote I; Karlan B; Lester J; Orsulic S; Walsh C; Fasching PA; Beckmann MW; Ekici AB; Hein A; Matsuo K; Hosono S; Pisterer J; Hillemanns P; Nakanishi T; Yatabe Y; Goodman MT; Lurie G; Matsuno RK; Thompson PJ; Pejovic T; Bean Y; Heitz F; Harter P; du Bois A; Schwaab I; Hogdall E; Kjaer SK; Jensen A; Hogdall C; Lundvall L; Engelholm SA; Brown B; Flanagan JM; Metcalf MD; Siddiqui N; Sellers T; Fridley B; Cunningham J; Schildkraut JM; Iversen E; Weber RP; Brennan D; Berchuck A; Pharoah P; Harnett P; Norris MD; Haber M; Goode EL; Lee JS; Khanna KK; Meyer KB; Chenevix-Trench G; deFazio A; Edwards SL; MacGregor S;
    Oncotarget; 2016 Feb; 7(6):6353-68. PubMed ID: 26840454
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Significance of lower uterine segment involvement in women with stage I endometrial adenocarcinoma.
    Gemer O; Uriev L; Harkovsky T; Peled R; Ben-Dor D; Barak F; Segal S
    J Reprod Med; 2004 Sep; 49(9):703-6. PubMed ID: 15493559
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.